Global General Anesthesia Drugs Supply, Demand and Key Producers, 2024-2030

Global General Anesthesia Drugs Supply, Demand and Key Producers, 2024-2030

Page: 137

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global General Anesthesia Drugs market size is expected to reach $ 5087.1 million by 2030, rising at a market growth of 3.3% CAGR during the forecast period (2024-2030).

Global key players of general anesthesia drugs include Fresenius-Kabi, Baxter Healthcare, Aspen Pharma, etc. The top three players hold a share about 37%. Americas is the largest market, has a share about 36%, followed by Asia-Pacific and Europe, with share 29% and 28%, separately.

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.

This report studies the global General Anesthesia Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for General Anesthesia Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of General Anesthesia Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global General Anesthesia Drugs total production and demand, 2019-2030, (M Units)
Global General Anesthesia Drugs total production value, 2019-2030, (USD Million)
Global General Anesthesia Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global General Anesthesia Drugs consumption by region & country, CAGR, 2019-2030 & (M Units)
U.S. VS China: General Anesthesia Drugs domestic production, consumption, key domestic manufacturers and share
Global General Anesthesia Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (M Units)
Global General Anesthesia Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global General Anesthesia Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (M Units).

This reports profiles key players in the global General Anesthesia Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals and Yichang Humanwell, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World General Anesthesia Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global General Anesthesia Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global General Anesthesia Drugs Market, Segmentation by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Others

Global General Anesthesia Drugs Market, Segmentation by Application
Intravenous Anesthetics
Inhalational Anesthetics

Companies Profiled:
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang

Key Questions Answered
1. How big is the global General Anesthesia Drugs market?
2. What is the demand of the global General Anesthesia Drugs market?
3. What is the year over year growth of the global General Anesthesia Drugs market?
4. What is the production and production value of the global General Anesthesia Drugs market?
5. Who are the key producers in the global General Anesthesia Drugs market?
btl

Table of Contents

1 Supply Summary
1.1 General Anesthesia Drugs Introduction
1.2 World General Anesthesia Drugs Supply & Forecast
1.2.1 World General Anesthesia Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World General Anesthesia Drugs Production (2019-2030)
1.2.3 World General Anesthesia Drugs Pricing Trends (2019-2030)
1.3 World General Anesthesia Drugs Production by Region (Based on Production Site)
1.3.1 World General Anesthesia Drugs Production Value by Region (2019-2030)
1.3.2 World General Anesthesia Drugs Production by Region (2019-2030)
1.3.3 World General Anesthesia Drugs Average Price by Region (2019-2030)
1.3.4 North America General Anesthesia Drugs Production (2019-2030)
1.3.5 Europe General Anesthesia Drugs Production (2019-2030)
1.3.6 China General Anesthesia Drugs Production (2019-2030)
1.3.7 Japan General Anesthesia Drugs Production (2019-2030)
1.3.8 India General Anesthesia Drugs Production (2019-2030)
1.3.9 South Africa General Anesthesia Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 General Anesthesia Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 General Anesthesia Drugs Major Market Trends

2 Demand Summary
2.1 World General Anesthesia Drugs Demand (2019-2030)
2.2 World General Anesthesia Drugs Consumption by Region
2.2.1 World General Anesthesia Drugs Consumption by Region (2019-2024)
2.2.2 World General Anesthesia Drugs Consumption Forecast by Region (2025-2030)
2.3 United States General Anesthesia Drugs Consumption (2019-2030)
2.4 China General Anesthesia Drugs Consumption (2019-2030)
2.5 Europe General Anesthesia Drugs Consumption (2019-2030)
2.6 Japan General Anesthesia Drugs Consumption (2019-2030)
2.7 South Korea General Anesthesia Drugs Consumption (2019-2030)
2.8 ASEAN General Anesthesia Drugs Consumption (2019-2030)
2.9 India General Anesthesia Drugs Consumption (2019-2030)

3 World General Anesthesia Drugs Manufacturers Competitive Analysis
3.1 World General Anesthesia Drugs Production Value by Manufacturer (2019-2024)
3.2 World General Anesthesia Drugs Production by Manufacturer (2019-2024)
3.3 World General Anesthesia Drugs Average Price by Manufacturer (2019-2024)
3.4 General Anesthesia Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global General Anesthesia Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for General Anesthesia Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for General Anesthesia Drugs in 2023
3.6 General Anesthesia Drugs Market: Overall Company Footprint Analysis
3.6.1 General Anesthesia Drugs Market: Region Footprint
3.6.2 General Anesthesia Drugs Market: Company Product Type Footprint
3.6.3 General Anesthesia Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: General Anesthesia Drugs Production Value Comparison
4.1.1 United States VS China: General Anesthesia Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: General Anesthesia Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: General Anesthesia Drugs Production Comparison
4.2.1 United States VS China: General Anesthesia Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: General Anesthesia Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: General Anesthesia Drugs Consumption Comparison
4.3.1 United States VS China: General Anesthesia Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: General Anesthesia Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based General Anesthesia Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers General Anesthesia Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers General Anesthesia Drugs Production (2019-2024)
4.5 China Based General Anesthesia Drugs Manufacturers and Market Share
4.5.1 China Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers General Anesthesia Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers General Anesthesia Drugs Production (2019-2024)
4.6 Rest of World Based General Anesthesia Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers General Anesthesia Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers General Anesthesia Drugs Production (2019-2024)

5 Market Analysis by Type
5.1 World General Anesthesia Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Propofol
5.2.2 Sevoflurane
5.2.3 Remifentanil
5.2.4 Etomidate
5.2.5 Isoflurane
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World General Anesthesia Drugs Production by Type (2019-2030)
5.3.2 World General Anesthesia Drugs Production Value by Type (2019-2030)
5.3.3 World General Anesthesia Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World General Anesthesia Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Intravenous Anesthetics
6.2.2 Inhalational Anesthetics
6.3 Market Segment by Application
6.3.1 World General Anesthesia Drugs Production by Application (2019-2030)
6.3.2 World General Anesthesia Drugs Production Value by Application (2019-2030)
6.3.3 World General Anesthesia Drugs Average Price by Application (2019-2030)

7 Company Profiles
7.1 Aspen Pharma
7.1.1 Aspen Pharma Details
7.1.2 Aspen Pharma Major Business
7.1.3 Aspen Pharma General Anesthesia Drugs Product and Services
7.1.4 Aspen Pharma General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Aspen Pharma Recent Developments/Updates
7.1.6 Aspen Pharma Competitive Strengths & Weaknesses
7.2 Fresenius-Kabi
7.2.1 Fresenius-Kabi Details
7.2.2 Fresenius-Kabi Major Business
7.2.3 Fresenius-Kabi General Anesthesia Drugs Product and Services
7.2.4 Fresenius-Kabi General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Fresenius-Kabi Recent Developments/Updates
7.2.6 Fresenius-Kabi Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie General Anesthesia Drugs Product and Services
7.3.4 AbbVie General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Baxter Healthcare
7.4.1 Baxter Healthcare Details
7.4.2 Baxter Healthcare Major Business
7.4.3 Baxter Healthcare General Anesthesia Drugs Product and Services
7.4.4 Baxter Healthcare General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Baxter Healthcare Recent Developments/Updates
7.4.6 Baxter Healthcare Competitive Strengths & Weaknesses
7.5 B.Braun
7.5.1 B.Braun Details
7.5.2 B.Braun Major Business
7.5.3 B.Braun General Anesthesia Drugs Product and Services
7.5.4 B.Braun General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 B.Braun Recent Developments/Updates
7.5.6 B.Braun Competitive Strengths & Weaknesses
7.6 Maruishi
7.6.1 Maruishi Details
7.6.2 Maruishi Major Business
7.6.3 Maruishi General Anesthesia Drugs Product and Services
7.6.4 Maruishi General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Maruishi Recent Developments/Updates
7.6.6 Maruishi Competitive Strengths & Weaknesses
7.7 Piramal
7.7.1 Piramal Details
7.7.2 Piramal Major Business
7.7.3 Piramal General Anesthesia Drugs Product and Services
7.7.4 Piramal General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Piramal Recent Developments/Updates
7.7.6 Piramal Competitive Strengths & Weaknesses
7.8 Hikma Pharmaceuticals
7.8.1 Hikma Pharmaceuticals Details
7.8.2 Hikma Pharmaceuticals Major Business
7.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Product and Services
7.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Hikma Pharmaceuticals Recent Developments/Updates
7.8.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Yichang Humanwell
7.9.1 Yichang Humanwell Details
7.9.2 Yichang Humanwell Major Business
7.9.3 Yichang Humanwell General Anesthesia Drugs Product and Services
7.9.4 Yichang Humanwell General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Yichang Humanwell Recent Developments/Updates
7.9.6 Yichang Humanwell Competitive Strengths & Weaknesses
7.10 Nhwa
7.10.1 Nhwa Details
7.10.2 Nhwa Major Business
7.10.3 Nhwa General Anesthesia Drugs Product and Services
7.10.4 Nhwa General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Nhwa Recent Developments/Updates
7.10.6 Nhwa Competitive Strengths & Weaknesses
7.11 Hengrui
7.11.1 Hengrui Details
7.11.2 Hengrui Major Business
7.11.3 Hengrui General Anesthesia Drugs Product and Services
7.11.4 Hengrui General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Hengrui Recent Developments/Updates
7.11.6 Hengrui Competitive Strengths & Weaknesses
7.12 Xi'an Libang
7.12.1 Xi'an Libang Details
7.12.2 Xi'an Libang Major Business
7.12.3 Xi'an Libang General Anesthesia Drugs Product and Services
7.12.4 Xi'an Libang General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Xi'an Libang Recent Developments/Updates
7.12.6 Xi'an Libang Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 General Anesthesia Drugs Industry Chain
8.2 General Anesthesia Drugs Upstream Analysis
8.2.1 General Anesthesia Drugs Core Raw Materials
8.2.2 Main Manufacturers of General Anesthesia Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 General Anesthesia Drugs Production Mode
8.6 General Anesthesia Drugs Procurement Model
8.7 General Anesthesia Drugs Industry Sales Model and Sales Channels
8.7.1 General Anesthesia Drugs Sales Model
8.7.2 General Anesthesia Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World General Anesthesia Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World General Anesthesia Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World General Anesthesia Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World General Anesthesia Drugs Production Value Market Share by Region (2019-2024)
Table 5. World General Anesthesia Drugs Production Value Market Share by Region (2025-2030)
Table 6. World General Anesthesia Drugs Production by Region (2019-2024) & (M Units)
Table 7. World General Anesthesia Drugs Production by Region (2025-2030) & (M Units)
Table 8. World General Anesthesia Drugs Production Market Share by Region (2019-2024)
Table 9. World General Anesthesia Drugs Production Market Share by Region (2025-2030)
Table 10. World General Anesthesia Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World General Anesthesia Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. General Anesthesia Drugs Major Market Trends
Table 13. World General Anesthesia Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (M Units)
Table 14. World General Anesthesia Drugs Consumption by Region (2019-2024) & (M Units)
Table 15. World General Anesthesia Drugs Consumption Forecast by Region (2025-2030) & (M Units)
Table 16. World General Anesthesia Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key General Anesthesia Drugs Producers in 2023
Table 18. World General Anesthesia Drugs Production by Manufacturer (2019-2024) & (M Units)
Table 19. Production Market Share of Key General Anesthesia Drugs Producers in 2023
Table 20. World General Anesthesia Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global General Anesthesia Drugs Company Evaluation Quadrant
Table 22. World General Anesthesia Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and General Anesthesia Drugs Production Site of Key Manufacturer
Table 24. General Anesthesia Drugs Market: Company Product Type Footprint
Table 25. General Anesthesia Drugs Market: Company Product Application Footprint
Table 26. General Anesthesia Drugs Competitive Factors
Table 27. General Anesthesia Drugs New Entrant and Capacity Expansion Plans
Table 28. General Anesthesia Drugs Mergers & Acquisitions Activity
Table 29. United States VS China General Anesthesia Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China General Anesthesia Drugs Production Comparison, (2019 & 2023 & 2030) & (M Units)
Table 31. United States VS China General Anesthesia Drugs Consumption Comparison, (2019 & 2023 & 2030) & (M Units)
Table 32. United States Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers General Anesthesia Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers General Anesthesia Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers General Anesthesia Drugs Production (2019-2024) & (M Units)
Table 36. United States Based Manufacturers General Anesthesia Drugs Production Market Share (2019-2024)
Table 37. China Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers General Anesthesia Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers General Anesthesia Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers General Anesthesia Drugs Production (2019-2024) & (M Units)
Table 41. China Based Manufacturers General Anesthesia Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers General Anesthesia Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers General Anesthesia Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers General Anesthesia Drugs Production (2019-2024) & (M Units)
Table 46. Rest of World Based Manufacturers General Anesthesia Drugs Production Market Share (2019-2024)
Table 47. World General Anesthesia Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World General Anesthesia Drugs Production by Type (2019-2024) & (M Units)
Table 49. World General Anesthesia Drugs Production by Type (2025-2030) & (M Units)
Table 50. World General Anesthesia Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World General Anesthesia Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World General Anesthesia Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World General Anesthesia Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World General Anesthesia Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World General Anesthesia Drugs Production by Application (2019-2024) & (M Units)
Table 56. World General Anesthesia Drugs Production by Application (2025-2030) & (M Units)
Table 57. World General Anesthesia Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World General Anesthesia Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World General Anesthesia Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World General Anesthesia Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Aspen Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Aspen Pharma Major Business
Table 63. Aspen Pharma General Anesthesia Drugs Product and Services
Table 64. Aspen Pharma General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Aspen Pharma Recent Developments/Updates
Table 66. Aspen Pharma Competitive Strengths & Weaknesses
Table 67. Fresenius-Kabi Basic Information, Manufacturing Base and Competitors
Table 68. Fresenius-Kabi Major Business
Table 69. Fresenius-Kabi General Anesthesia Drugs Product and Services
Table 70. Fresenius-Kabi General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Fresenius-Kabi Recent Developments/Updates
Table 72. Fresenius-Kabi Competitive Strengths & Weaknesses
Table 73. AbbVie Basic Information, Manufacturing Base and Competitors
Table 74. AbbVie Major Business
Table 75. AbbVie General Anesthesia Drugs Product and Services
Table 76. AbbVie General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. AbbVie Recent Developments/Updates
Table 78. AbbVie Competitive Strengths & Weaknesses
Table 79. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Baxter Healthcare Major Business
Table 81. Baxter Healthcare General Anesthesia Drugs Product and Services
Table 82. Baxter Healthcare General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Baxter Healthcare Recent Developments/Updates
Table 84. Baxter Healthcare Competitive Strengths & Weaknesses
Table 85. B.Braun Basic Information, Manufacturing Base and Competitors
Table 86. B.Braun Major Business
Table 87. B.Braun General Anesthesia Drugs Product and Services
Table 88. B.Braun General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. B.Braun Recent Developments/Updates
Table 90. B.Braun Competitive Strengths & Weaknesses
Table 91. Maruishi Basic Information, Manufacturing Base and Competitors
Table 92. Maruishi Major Business
Table 93. Maruishi General Anesthesia Drugs Product and Services
Table 94. Maruishi General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Maruishi Recent Developments/Updates
Table 96. Maruishi Competitive Strengths & Weaknesses
Table 97. Piramal Basic Information, Manufacturing Base and Competitors
Table 98. Piramal Major Business
Table 99. Piramal General Anesthesia Drugs Product and Services
Table 100. Piramal General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Piramal Recent Developments/Updates
Table 102. Piramal Competitive Strengths & Weaknesses
Table 103. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Hikma Pharmaceuticals Major Business
Table 105. Hikma Pharmaceuticals General Anesthesia Drugs Product and Services
Table 106. Hikma Pharmaceuticals General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Hikma Pharmaceuticals Recent Developments/Updates
Table 108. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Yichang Humanwell Basic Information, Manufacturing Base and Competitors
Table 110. Yichang Humanwell Major Business
Table 111. Yichang Humanwell General Anesthesia Drugs Product and Services
Table 112. Yichang Humanwell General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Yichang Humanwell Recent Developments/Updates
Table 114. Yichang Humanwell Competitive Strengths & Weaknesses
Table 115. Nhwa Basic Information, Manufacturing Base and Competitors
Table 116. Nhwa Major Business
Table 117. Nhwa General Anesthesia Drugs Product and Services
Table 118. Nhwa General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Nhwa Recent Developments/Updates
Table 120. Nhwa Competitive Strengths & Weaknesses
Table 121. Hengrui Basic Information, Manufacturing Base and Competitors
Table 122. Hengrui Major Business
Table 123. Hengrui General Anesthesia Drugs Product and Services
Table 124. Hengrui General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Hengrui Recent Developments/Updates
Table 126. Xi'an Libang Basic Information, Manufacturing Base and Competitors
Table 127. Xi'an Libang Major Business
Table 128. Xi'an Libang General Anesthesia Drugs Product and Services
Table 129. Xi'an Libang General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 130. Global Key Players of General Anesthesia Drugs Upstream (Raw Materials)
Table 131. General Anesthesia Drugs Typical Customers
Table 132. General Anesthesia Drugs Typical Distributors
List of Figure
Figure 1. General Anesthesia Drugs Picture
Figure 2. World General Anesthesia Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World General Anesthesia Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 5. World General Anesthesia Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World General Anesthesia Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World General Anesthesia Drugs Production Market Share by Region (2019-2030)
Figure 8. North America General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 9. Europe General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 10. China General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 11. Japan General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 12. India General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 13. South Africa General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 14. General Anesthesia Drugs Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 17. World General Anesthesia Drugs Consumption Market Share by Region (2019-2030)
Figure 18. United States General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 19. China General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 20. Europe General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 21. Japan General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 22. South Korea General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 23. ASEAN General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 24. India General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 25. Producer Shipments of General Anesthesia Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 26. Global Four-firm Concentration Ratios (CR4) for General Anesthesia Drugs Markets in 2023
Figure 27. Global Four-firm Concentration Ratios (CR8) for General Anesthesia Drugs Markets in 2023
Figure 28. United States VS China: General Anesthesia Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: General Anesthesia Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States VS China: General Anesthesia Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 31. United States Based Manufacturers General Anesthesia Drugs Production Market Share 2023
Figure 32. China Based Manufacturers General Anesthesia Drugs Production Market Share 2023
Figure 33. Rest of World Based Manufacturers General Anesthesia Drugs Production Market Share 2023
Figure 34. World General Anesthesia Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 35. World General Anesthesia Drugs Production Value Market Share by Type in 2023
Figure 36. Propofol
Figure 37. Sevoflurane
Figure 38. Remifentanil
Figure 39. Etomidate
Figure 40. Isoflurane
Figure 41. Others
Figure 42. World General Anesthesia Drugs Production Market Share by Type (2019-2030)
Figure 43. World General Anesthesia Drugs Production Value Market Share by Type (2019-2030)
Figure 44. World General Anesthesia Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 45. World General Anesthesia Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 46. World General Anesthesia Drugs Production Value Market Share by Application in 2023
Figure 47. Intravenous Anesthetics
Figure 48. Inhalational Anesthetics
Figure 49. World General Anesthesia Drugs Production Market Share by Application (2019-2030)
Figure 50. World General Anesthesia Drugs Production Value Market Share by Application (2019-2030)
Figure 51. World General Anesthesia Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 52. General Anesthesia Drugs Industry Chain
Figure 53. General Anesthesia Drugs Procurement Model
Figure 54. General Anesthesia Drugs Sales Model
Figure 55. General Anesthesia Drugs Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global General Anesthesia Drugs Supply, Demand and Key Producers, 2024-2030

Global General Anesthesia Drugs Supply, Demand and Key Producers, 2024-2030

Page: 137

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global General Anesthesia Drugs market size is expected to reach $ 5087.1 million by 2030, rising at a market growth of 3.3% CAGR during the forecast period (2024-2030).

Global key players of general anesthesia drugs include Fresenius-Kabi, Baxter Healthcare, Aspen Pharma, etc. The top three players hold a share about 37%. Americas is the largest market, has a share about 36%, followed by Asia-Pacific and Europe, with share 29% and 28%, separately.

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.

This report studies the global General Anesthesia Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for General Anesthesia Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of General Anesthesia Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global General Anesthesia Drugs total production and demand, 2019-2030, (M Units)
Global General Anesthesia Drugs total production value, 2019-2030, (USD Million)
Global General Anesthesia Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global General Anesthesia Drugs consumption by region & country, CAGR, 2019-2030 & (M Units)
U.S. VS China: General Anesthesia Drugs domestic production, consumption, key domestic manufacturers and share
Global General Anesthesia Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (M Units)
Global General Anesthesia Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global General Anesthesia Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (M Units).

This reports profiles key players in the global General Anesthesia Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals and Yichang Humanwell, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World General Anesthesia Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global General Anesthesia Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global General Anesthesia Drugs Market, Segmentation by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Others

Global General Anesthesia Drugs Market, Segmentation by Application
Intravenous Anesthetics
Inhalational Anesthetics

Companies Profiled:
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang

Key Questions Answered
1. How big is the global General Anesthesia Drugs market?
2. What is the demand of the global General Anesthesia Drugs market?
3. What is the year over year growth of the global General Anesthesia Drugs market?
4. What is the production and production value of the global General Anesthesia Drugs market?
5. Who are the key producers in the global General Anesthesia Drugs market?
btl

Table of Contents

1 Supply Summary
1.1 General Anesthesia Drugs Introduction
1.2 World General Anesthesia Drugs Supply & Forecast
1.2.1 World General Anesthesia Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World General Anesthesia Drugs Production (2019-2030)
1.2.3 World General Anesthesia Drugs Pricing Trends (2019-2030)
1.3 World General Anesthesia Drugs Production by Region (Based on Production Site)
1.3.1 World General Anesthesia Drugs Production Value by Region (2019-2030)
1.3.2 World General Anesthesia Drugs Production by Region (2019-2030)
1.3.3 World General Anesthesia Drugs Average Price by Region (2019-2030)
1.3.4 North America General Anesthesia Drugs Production (2019-2030)
1.3.5 Europe General Anesthesia Drugs Production (2019-2030)
1.3.6 China General Anesthesia Drugs Production (2019-2030)
1.3.7 Japan General Anesthesia Drugs Production (2019-2030)
1.3.8 India General Anesthesia Drugs Production (2019-2030)
1.3.9 South Africa General Anesthesia Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 General Anesthesia Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 General Anesthesia Drugs Major Market Trends

2 Demand Summary
2.1 World General Anesthesia Drugs Demand (2019-2030)
2.2 World General Anesthesia Drugs Consumption by Region
2.2.1 World General Anesthesia Drugs Consumption by Region (2019-2024)
2.2.2 World General Anesthesia Drugs Consumption Forecast by Region (2025-2030)
2.3 United States General Anesthesia Drugs Consumption (2019-2030)
2.4 China General Anesthesia Drugs Consumption (2019-2030)
2.5 Europe General Anesthesia Drugs Consumption (2019-2030)
2.6 Japan General Anesthesia Drugs Consumption (2019-2030)
2.7 South Korea General Anesthesia Drugs Consumption (2019-2030)
2.8 ASEAN General Anesthesia Drugs Consumption (2019-2030)
2.9 India General Anesthesia Drugs Consumption (2019-2030)

3 World General Anesthesia Drugs Manufacturers Competitive Analysis
3.1 World General Anesthesia Drugs Production Value by Manufacturer (2019-2024)
3.2 World General Anesthesia Drugs Production by Manufacturer (2019-2024)
3.3 World General Anesthesia Drugs Average Price by Manufacturer (2019-2024)
3.4 General Anesthesia Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global General Anesthesia Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for General Anesthesia Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for General Anesthesia Drugs in 2023
3.6 General Anesthesia Drugs Market: Overall Company Footprint Analysis
3.6.1 General Anesthesia Drugs Market: Region Footprint
3.6.2 General Anesthesia Drugs Market: Company Product Type Footprint
3.6.3 General Anesthesia Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: General Anesthesia Drugs Production Value Comparison
4.1.1 United States VS China: General Anesthesia Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: General Anesthesia Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: General Anesthesia Drugs Production Comparison
4.2.1 United States VS China: General Anesthesia Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: General Anesthesia Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: General Anesthesia Drugs Consumption Comparison
4.3.1 United States VS China: General Anesthesia Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: General Anesthesia Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based General Anesthesia Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers General Anesthesia Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers General Anesthesia Drugs Production (2019-2024)
4.5 China Based General Anesthesia Drugs Manufacturers and Market Share
4.5.1 China Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers General Anesthesia Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers General Anesthesia Drugs Production (2019-2024)
4.6 Rest of World Based General Anesthesia Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers General Anesthesia Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers General Anesthesia Drugs Production (2019-2024)

5 Market Analysis by Type
5.1 World General Anesthesia Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Propofol
5.2.2 Sevoflurane
5.2.3 Remifentanil
5.2.4 Etomidate
5.2.5 Isoflurane
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World General Anesthesia Drugs Production by Type (2019-2030)
5.3.2 World General Anesthesia Drugs Production Value by Type (2019-2030)
5.3.3 World General Anesthesia Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World General Anesthesia Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Intravenous Anesthetics
6.2.2 Inhalational Anesthetics
6.3 Market Segment by Application
6.3.1 World General Anesthesia Drugs Production by Application (2019-2030)
6.3.2 World General Anesthesia Drugs Production Value by Application (2019-2030)
6.3.3 World General Anesthesia Drugs Average Price by Application (2019-2030)

7 Company Profiles
7.1 Aspen Pharma
7.1.1 Aspen Pharma Details
7.1.2 Aspen Pharma Major Business
7.1.3 Aspen Pharma General Anesthesia Drugs Product and Services
7.1.4 Aspen Pharma General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Aspen Pharma Recent Developments/Updates
7.1.6 Aspen Pharma Competitive Strengths & Weaknesses
7.2 Fresenius-Kabi
7.2.1 Fresenius-Kabi Details
7.2.2 Fresenius-Kabi Major Business
7.2.3 Fresenius-Kabi General Anesthesia Drugs Product and Services
7.2.4 Fresenius-Kabi General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Fresenius-Kabi Recent Developments/Updates
7.2.6 Fresenius-Kabi Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie General Anesthesia Drugs Product and Services
7.3.4 AbbVie General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Baxter Healthcare
7.4.1 Baxter Healthcare Details
7.4.2 Baxter Healthcare Major Business
7.4.3 Baxter Healthcare General Anesthesia Drugs Product and Services
7.4.4 Baxter Healthcare General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Baxter Healthcare Recent Developments/Updates
7.4.6 Baxter Healthcare Competitive Strengths & Weaknesses
7.5 B.Braun
7.5.1 B.Braun Details
7.5.2 B.Braun Major Business
7.5.3 B.Braun General Anesthesia Drugs Product and Services
7.5.4 B.Braun General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 B.Braun Recent Developments/Updates
7.5.6 B.Braun Competitive Strengths & Weaknesses
7.6 Maruishi
7.6.1 Maruishi Details
7.6.2 Maruishi Major Business
7.6.3 Maruishi General Anesthesia Drugs Product and Services
7.6.4 Maruishi General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Maruishi Recent Developments/Updates
7.6.6 Maruishi Competitive Strengths & Weaknesses
7.7 Piramal
7.7.1 Piramal Details
7.7.2 Piramal Major Business
7.7.3 Piramal General Anesthesia Drugs Product and Services
7.7.4 Piramal General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Piramal Recent Developments/Updates
7.7.6 Piramal Competitive Strengths & Weaknesses
7.8 Hikma Pharmaceuticals
7.8.1 Hikma Pharmaceuticals Details
7.8.2 Hikma Pharmaceuticals Major Business
7.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Product and Services
7.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Hikma Pharmaceuticals Recent Developments/Updates
7.8.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Yichang Humanwell
7.9.1 Yichang Humanwell Details
7.9.2 Yichang Humanwell Major Business
7.9.3 Yichang Humanwell General Anesthesia Drugs Product and Services
7.9.4 Yichang Humanwell General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Yichang Humanwell Recent Developments/Updates
7.9.6 Yichang Humanwell Competitive Strengths & Weaknesses
7.10 Nhwa
7.10.1 Nhwa Details
7.10.2 Nhwa Major Business
7.10.3 Nhwa General Anesthesia Drugs Product and Services
7.10.4 Nhwa General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Nhwa Recent Developments/Updates
7.10.6 Nhwa Competitive Strengths & Weaknesses
7.11 Hengrui
7.11.1 Hengrui Details
7.11.2 Hengrui Major Business
7.11.3 Hengrui General Anesthesia Drugs Product and Services
7.11.4 Hengrui General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Hengrui Recent Developments/Updates
7.11.6 Hengrui Competitive Strengths & Weaknesses
7.12 Xi'an Libang
7.12.1 Xi'an Libang Details
7.12.2 Xi'an Libang Major Business
7.12.3 Xi'an Libang General Anesthesia Drugs Product and Services
7.12.4 Xi'an Libang General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Xi'an Libang Recent Developments/Updates
7.12.6 Xi'an Libang Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 General Anesthesia Drugs Industry Chain
8.2 General Anesthesia Drugs Upstream Analysis
8.2.1 General Anesthesia Drugs Core Raw Materials
8.2.2 Main Manufacturers of General Anesthesia Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 General Anesthesia Drugs Production Mode
8.6 General Anesthesia Drugs Procurement Model
8.7 General Anesthesia Drugs Industry Sales Model and Sales Channels
8.7.1 General Anesthesia Drugs Sales Model
8.7.2 General Anesthesia Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World General Anesthesia Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World General Anesthesia Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World General Anesthesia Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World General Anesthesia Drugs Production Value Market Share by Region (2019-2024)
Table 5. World General Anesthesia Drugs Production Value Market Share by Region (2025-2030)
Table 6. World General Anesthesia Drugs Production by Region (2019-2024) & (M Units)
Table 7. World General Anesthesia Drugs Production by Region (2025-2030) & (M Units)
Table 8. World General Anesthesia Drugs Production Market Share by Region (2019-2024)
Table 9. World General Anesthesia Drugs Production Market Share by Region (2025-2030)
Table 10. World General Anesthesia Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World General Anesthesia Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. General Anesthesia Drugs Major Market Trends
Table 13. World General Anesthesia Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (M Units)
Table 14. World General Anesthesia Drugs Consumption by Region (2019-2024) & (M Units)
Table 15. World General Anesthesia Drugs Consumption Forecast by Region (2025-2030) & (M Units)
Table 16. World General Anesthesia Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key General Anesthesia Drugs Producers in 2023
Table 18. World General Anesthesia Drugs Production by Manufacturer (2019-2024) & (M Units)
Table 19. Production Market Share of Key General Anesthesia Drugs Producers in 2023
Table 20. World General Anesthesia Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global General Anesthesia Drugs Company Evaluation Quadrant
Table 22. World General Anesthesia Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and General Anesthesia Drugs Production Site of Key Manufacturer
Table 24. General Anesthesia Drugs Market: Company Product Type Footprint
Table 25. General Anesthesia Drugs Market: Company Product Application Footprint
Table 26. General Anesthesia Drugs Competitive Factors
Table 27. General Anesthesia Drugs New Entrant and Capacity Expansion Plans
Table 28. General Anesthesia Drugs Mergers & Acquisitions Activity
Table 29. United States VS China General Anesthesia Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China General Anesthesia Drugs Production Comparison, (2019 & 2023 & 2030) & (M Units)
Table 31. United States VS China General Anesthesia Drugs Consumption Comparison, (2019 & 2023 & 2030) & (M Units)
Table 32. United States Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers General Anesthesia Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers General Anesthesia Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers General Anesthesia Drugs Production (2019-2024) & (M Units)
Table 36. United States Based Manufacturers General Anesthesia Drugs Production Market Share (2019-2024)
Table 37. China Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers General Anesthesia Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers General Anesthesia Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers General Anesthesia Drugs Production (2019-2024) & (M Units)
Table 41. China Based Manufacturers General Anesthesia Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based General Anesthesia Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers General Anesthesia Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers General Anesthesia Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers General Anesthesia Drugs Production (2019-2024) & (M Units)
Table 46. Rest of World Based Manufacturers General Anesthesia Drugs Production Market Share (2019-2024)
Table 47. World General Anesthesia Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World General Anesthesia Drugs Production by Type (2019-2024) & (M Units)
Table 49. World General Anesthesia Drugs Production by Type (2025-2030) & (M Units)
Table 50. World General Anesthesia Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World General Anesthesia Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World General Anesthesia Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World General Anesthesia Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World General Anesthesia Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World General Anesthesia Drugs Production by Application (2019-2024) & (M Units)
Table 56. World General Anesthesia Drugs Production by Application (2025-2030) & (M Units)
Table 57. World General Anesthesia Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World General Anesthesia Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World General Anesthesia Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World General Anesthesia Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Aspen Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Aspen Pharma Major Business
Table 63. Aspen Pharma General Anesthesia Drugs Product and Services
Table 64. Aspen Pharma General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Aspen Pharma Recent Developments/Updates
Table 66. Aspen Pharma Competitive Strengths & Weaknesses
Table 67. Fresenius-Kabi Basic Information, Manufacturing Base and Competitors
Table 68. Fresenius-Kabi Major Business
Table 69. Fresenius-Kabi General Anesthesia Drugs Product and Services
Table 70. Fresenius-Kabi General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Fresenius-Kabi Recent Developments/Updates
Table 72. Fresenius-Kabi Competitive Strengths & Weaknesses
Table 73. AbbVie Basic Information, Manufacturing Base and Competitors
Table 74. AbbVie Major Business
Table 75. AbbVie General Anesthesia Drugs Product and Services
Table 76. AbbVie General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. AbbVie Recent Developments/Updates
Table 78. AbbVie Competitive Strengths & Weaknesses
Table 79. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Baxter Healthcare Major Business
Table 81. Baxter Healthcare General Anesthesia Drugs Product and Services
Table 82. Baxter Healthcare General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Baxter Healthcare Recent Developments/Updates
Table 84. Baxter Healthcare Competitive Strengths & Weaknesses
Table 85. B.Braun Basic Information, Manufacturing Base and Competitors
Table 86. B.Braun Major Business
Table 87. B.Braun General Anesthesia Drugs Product and Services
Table 88. B.Braun General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. B.Braun Recent Developments/Updates
Table 90. B.Braun Competitive Strengths & Weaknesses
Table 91. Maruishi Basic Information, Manufacturing Base and Competitors
Table 92. Maruishi Major Business
Table 93. Maruishi General Anesthesia Drugs Product and Services
Table 94. Maruishi General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Maruishi Recent Developments/Updates
Table 96. Maruishi Competitive Strengths & Weaknesses
Table 97. Piramal Basic Information, Manufacturing Base and Competitors
Table 98. Piramal Major Business
Table 99. Piramal General Anesthesia Drugs Product and Services
Table 100. Piramal General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Piramal Recent Developments/Updates
Table 102. Piramal Competitive Strengths & Weaknesses
Table 103. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Hikma Pharmaceuticals Major Business
Table 105. Hikma Pharmaceuticals General Anesthesia Drugs Product and Services
Table 106. Hikma Pharmaceuticals General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Hikma Pharmaceuticals Recent Developments/Updates
Table 108. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Yichang Humanwell Basic Information, Manufacturing Base and Competitors
Table 110. Yichang Humanwell Major Business
Table 111. Yichang Humanwell General Anesthesia Drugs Product and Services
Table 112. Yichang Humanwell General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Yichang Humanwell Recent Developments/Updates
Table 114. Yichang Humanwell Competitive Strengths & Weaknesses
Table 115. Nhwa Basic Information, Manufacturing Base and Competitors
Table 116. Nhwa Major Business
Table 117. Nhwa General Anesthesia Drugs Product and Services
Table 118. Nhwa General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Nhwa Recent Developments/Updates
Table 120. Nhwa Competitive Strengths & Weaknesses
Table 121. Hengrui Basic Information, Manufacturing Base and Competitors
Table 122. Hengrui Major Business
Table 123. Hengrui General Anesthesia Drugs Product and Services
Table 124. Hengrui General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Hengrui Recent Developments/Updates
Table 126. Xi'an Libang Basic Information, Manufacturing Base and Competitors
Table 127. Xi'an Libang Major Business
Table 128. Xi'an Libang General Anesthesia Drugs Product and Services
Table 129. Xi'an Libang General Anesthesia Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 130. Global Key Players of General Anesthesia Drugs Upstream (Raw Materials)
Table 131. General Anesthesia Drugs Typical Customers
Table 132. General Anesthesia Drugs Typical Distributors
List of Figure
Figure 1. General Anesthesia Drugs Picture
Figure 2. World General Anesthesia Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World General Anesthesia Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 5. World General Anesthesia Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World General Anesthesia Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World General Anesthesia Drugs Production Market Share by Region (2019-2030)
Figure 8. North America General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 9. Europe General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 10. China General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 11. Japan General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 12. India General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 13. South Africa General Anesthesia Drugs Production (2019-2030) & (M Units)
Figure 14. General Anesthesia Drugs Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 17. World General Anesthesia Drugs Consumption Market Share by Region (2019-2030)
Figure 18. United States General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 19. China General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 20. Europe General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 21. Japan General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 22. South Korea General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 23. ASEAN General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 24. India General Anesthesia Drugs Consumption (2019-2030) & (M Units)
Figure 25. Producer Shipments of General Anesthesia Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 26. Global Four-firm Concentration Ratios (CR4) for General Anesthesia Drugs Markets in 2023
Figure 27. Global Four-firm Concentration Ratios (CR8) for General Anesthesia Drugs Markets in 2023
Figure 28. United States VS China: General Anesthesia Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: General Anesthesia Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States VS China: General Anesthesia Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 31. United States Based Manufacturers General Anesthesia Drugs Production Market Share 2023
Figure 32. China Based Manufacturers General Anesthesia Drugs Production Market Share 2023
Figure 33. Rest of World Based Manufacturers General Anesthesia Drugs Production Market Share 2023
Figure 34. World General Anesthesia Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 35. World General Anesthesia Drugs Production Value Market Share by Type in 2023
Figure 36. Propofol
Figure 37. Sevoflurane
Figure 38. Remifentanil
Figure 39. Etomidate
Figure 40. Isoflurane
Figure 41. Others
Figure 42. World General Anesthesia Drugs Production Market Share by Type (2019-2030)
Figure 43. World General Anesthesia Drugs Production Value Market Share by Type (2019-2030)
Figure 44. World General Anesthesia Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 45. World General Anesthesia Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 46. World General Anesthesia Drugs Production Value Market Share by Application in 2023
Figure 47. Intravenous Anesthetics
Figure 48. Inhalational Anesthetics
Figure 49. World General Anesthesia Drugs Production Market Share by Application (2019-2030)
Figure 50. World General Anesthesia Drugs Production Value Market Share by Application (2019-2030)
Figure 51. World General Anesthesia Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 52. General Anesthesia Drugs Industry Chain
Figure 53. General Anesthesia Drugs Procurement Model
Figure 54. General Anesthesia Drugs Sales Model
Figure 55. General Anesthesia Drugs Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
jiaGou

Add To Cart

gouMai

Buy Now